FINESSE: testing treatments for prostate cancer content
Using an existing medication that slows prostate growth, Finasteride, this trial will test whether the medication can reduce the need forextensive surgery or radiotherapy in men with early stage prostate cancer. The six-year trial will involve 550 men in Yorkshire.
Researchers
James Catto
Professor of Urology at the University of Sheffield
Peter Sasieni
Professor of Cancer Prevention at King's College London
Every 17 minutes someone is diagnosed with cancer in Yorkshire
Our aim is for more people to survive cancer, here in Yorkshire and beyond.
Please help us continue to fund life-saving research.
Improving surgical outcomes for bowel cancer
A randomised placebo-controlled phase III trial of the effect of the omega-3 fatty acid eicosapentaenoic acid…
CAPTURE: Cancer pain-assessment toolkit
This trial will investigate whether an existing pain assessment tool can be successfully adapted and…
Aurora: Enhanced radiotherapy for rectal cancer
This trial will test whether radiotherapy can be made more effective for people with some types of advanced…